Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs https://www.biorxiv.org/content/10.1101/2023.01.17.524372v1?med=mas
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs https://www.biorxiv.org/content/10.1101/2023.01.17.524372v1?med=mas